[en] Distinctive structural, chemical, and physical properties make the diarylmethane scaffold an essential constituent of many active biomolecules nowadays used in pharmaceutical, agrochemical, and material sciences. In this work, 33 novel diarylmethane molecules aiming to target colorectal cancer were designed. Two series of functionalized olefinic and aryloxy diarylmethanes were synthesized and chemically characterized. The synthetic strategy of olefinic diarylmethanes involved a McMurry cross-coupling reaction as key step and the synthesis of aryloxy diarylmethanes included an O-arylation step. A preliminarily screening in human colorectal cancer cells (HT-29 and HCT116) and murine primary fibroblasts (L929) allowed the selection, for more detailed analyses, of the three best candidates (10a, 10b and 12a) based on their high inhibition of cancer cell proliferation and non-toxic effects on murine fibroblasts (<100 µM). The anticancer potential of these diarylmethane compounds was then assessed using apoptotic (phospho-p38) and anti-apoptotic (phospho-ERK, phospho-Akt) cell survival signaling pathways, by analyzing the DNA fragmentation capacity, and through the caspase-3 and PARP cleavage pro-apoptotic markers. Compound 12a (2-(1-(4-methoxyphenyl)-2-(4-(trifluoromethyl)phenyl) vinyl) pyridine, Z isomer) was found to be the most active molecule. The binding mode to five biological targets (i.e., AKT, ERK-1 and ERK-2, PARP, and caspase-3) was explored using molecular modeling, and AKT was identified as the most interesting target. Finally, compounds 10a, 10b and 12a were predicted to have appropriate drug-likeness and good Absorption, Distribution, Metabolism and Excretion (ADME) profiles.
Goya-Jorge, Elizabeth ; Université de Liège - ULiège > Département de sciences des denrées alimentaires (DDA) > Gestion de la qualité dans la chaîne alimentaire
Mouhsine, Hadley
Msaddek, Moncef
Liagre, Bertrand ; UNILIM - Université de Limoges [FR] > LABCiS, UR 22722, Faculté de Pharmacie > F-87000 Limoges, France
Sylla-Iyarreta Veitía, Maité ; Conservatoire National des Arts et Métiers, HESAM Université > Laboratoire Génomique, Bioinformatique et Chimie Moléculaire (GBCM, EA 7528) > 2 rue Conté, 75003 Paris, France
Language :
English
Title :
Novel Set of Diarylmethanes to Target Colorectal Cancer: Synthesis, In Vitro and In Silico Studies
Goyal M. Singh P. Alam A. Das S.K. Iqbal M.S. Dey S. Bindu S. Pal C. Das S.K. Panda G. et al. Aryl aryl methyl thio arenes prevent multidrug-resistant malaria in mouse by promoting oxidative stress in parasites Free Radic. Biol. Med. 2012 53 129 142 10.1016/j.freeradbiomed.2012.04.028 22588006
Görmen M. Veitía M.S.-I. Trigui F. El Arbi M. Ferroud C. Ferrocenyl analogues of bisacodyl: Synthesis and antimicrobial activity J. Organomet. Chem. 2015 794 274 281 10.1016/j.jorganchem.2015.07.016
Cardinal S. Paquet-Côté P.-A. Azelmat J. Bouchard C. Grenier D. Voyer N. Synthesis and anti-inflammatory activity of isoquebecol Bioorg. Med. Chem. 2017 25 2043 2056 10.1016/j.bmc.2017.01.050 28258800
Cardinal S. Azelmat J. Grenier D. Voyer N. Anti-inflammatory properties of quebecol and its derivatives Bioorg. Med. Chem. Lett. 2016 26 440 444 10.1016/j.bmcl.2015.11.096
Alexander R. Warrellow G. Eaton M. Boyd E. Head J. Porter J. Brown J. Reuberson J. Hutchinson B. Turner P. et al. CDP840. A prototype of a novel class of orally active anti-Inflammatory phosphodiesterase 4 inhibitors Bioorg. Med. Chem. Lett. 2002 12 1451 1456 10.1016/S0960-894X(02)00202-0
Rioux B. Pouget C. Fidanzi-Dugas C. Gamond A. Laurent A. Semaan J. Pinon A. Champavier Y. Léger D.Y. Liagre B. et al. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents Bioorg. Med. Chem. Lett. 2017 27 4354 4357 10.1016/j.bmcl.2017.08.024
Houpis I.N. Lee J. Dorziotis I. Molina A. Reamer B. Volante R. Reider P.J. Ni-catalyzed nucleophilic conjugate additions of Grignard and organozincate reagents to substituted 4-vinylpyridines. General synthesis of phosphodiesterase IV inhibitors Tetrahedron 1998 54 1185 1195 10.1016/S0040-4020(97)10217-4
Pericherla K. Shirazi A.N. Rao V.K. Tiwari R.K. DaSilva N. McCaffrey K.T. Beni Y.A. González-Sarrías A. Seeram N.P. Parang K. et al. Synthesis and antiproliferative activities of quebecol and its analogs Bioorg. Med. Chem. Lett. 2013 23 5329 5331 10.1016/j.bmcl.2013.07.058
Valavaara R. Pyrhönen S. Heikkinen M. Rissanen P. Blanco G. Thölix E. Nordman E. Taskinen P. Holsti L. Hajba A. Toremifene, a new antiestrogenic compound, for treatment of advanced breast cancer. Phase II study Eur. J. Cancer Clin. Oncol. 1988 24 785 790 10.1016/0277-5379(88)90316-1
Vessières A. Top S. Beck W. Hillard E. Jaouen G. Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects Dalton Trans. 2006 529 541 10.1039/B509984F
Köpf-Maier P. Complexes of metals other than platinum as antitumour agents Eur. J. Clin. Pharmacol. 1994 47 1 16 10.1007/BF00193472 7988618
Heilmann J.B. Hillard E.A. Plamont M.-A. Pigeon P. Bolte M. Jaouen G. Vessières A. Ferrocenyl compounds possessing protected phenol and thiophenol groups: Synthesis, X-ray structure, and in vitro biological effects against breast cancer J. Organomet. Chem. 2008 693 1716 1722 10.1016/j.jorganchem.2007.12.011
Top S. Vessières A. Leclercq G. Quivy J. Tang J. Vaissermann J. Huché M. Jaouen G. Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone-Dependent and Hormone-Independent Breast Cancer Cell Lines Chem.-A Eur. J. 2003 9 5223 5236 10.1002/chem.200305024
Pigeon P. Top S. Zekri O. Hillard E.A. Vessières A. Plamont M.-A. Buriez O. Labbé E. Huché M. Boutamine S. et al. The replacement of a phenol group by an aniline or acetanilide group enhances the cytotoxicity of 2-ferrocenyl-1,1-diphenyl-but-l-ene compounds against breast cancer cells J. Organomet. Chem. 2009 694 895 901 10.1016/j.jorganchem.2008.11.035
Guay D. Hamel P. Blouin M. Brideau C. Chan C.C. Chauret N. Ducharme Y. Huang Z. Girard M. Jones T.R. et al. Discovery of L-791,943: A potent, selective, non emetic and orally active phosphodiesterase-4 inhibitor Bioorg. Med. Chem. Lett. 2002 12 1457 1461 10.1016/S0960-894X(02)00190-7
Legault J. Girard-Lalancette K. Grenon C. Dussault C. Pichette A. Antioxidant Activity, Inhibition of Nitric Oxide Overproduction, and In Vitro Antiproliferative Effect of Maple Sap and Syrup from Acer saccharum J. Med. Food 2010 13 460 468 10.1089/jmf.2009.0029
Ducharme Y. Friesen R.W. Blouin M. Côté B. Dubé D. Ethier D. Frenette R. Laliberté F. Mancini J.A. Masson P. et al. Substituted 2-Pyridinemethanol derivatives as potent and selective phosphodiesterase-4 inhibitors Bioorg. Med. Chem. Lett. 2003 13 1923 1926 10.1016/S0960-894X(03)00314-7
Smolobochkin A.V. Gazizov A.S. Yakhshilikova L.J. Bekrenev D.D. Burilov A.R. Pudovik M.A. Lyubina A.P. Amerhanova S.K. Voloshina A.D. Synthesis and Biological Evaluation of Taurine-Derived Diarylmethane and Dibenzoxanthene Derivatives as Possible Cytotoxic and Antimicrobial Agents Chem. Biodivers. 2022 19 e202100970 10.1002/cbdv.202100970
Parida S.K. Hota S.K. Jaiswal S. Singh P. Murarka S. Multicomponent Synthesis of Biologically Relevant S-Diarylmethane Dithiocarbamates Using p-Quinone Methides Adv. Synth. Catal. 2022 364 1549 1554 10.1002/adsc.202200029
Wang C. Wang B. Hou S. Xue L. Kang Z. Du J. Li Y. Liu X. Wang Q. Zhang C. Corrigendum to “Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer” [Eur. J. Med. Chem. 163 (2019) 787–803] Eur. J. Med. Chem. 2020 186 111907 10.1016/j.ejmech.2019.111907
Wang C. Wang B. Hou S. Xue L. Kang Z. Du J. Li Y. Liu X. Wang Q. Zhang C. Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer Eur. J. Med. Chem. 2019 163 787 803 10.1016/j.ejmech.2018.12.024 30579121
Qu C. Gao L. Tang Y. Liu Y. Luo X. Song G. Metal-Free Reductive Coupling of para-Quinone Methides with 4-Cyanopyridines Enabled by Pyridine-Boryl Radicals: Access to Pyridylated Diarylmethanes with Anti-Cancer Activity Chem.–A Eur. J. 2022 28 e202200264 10.1002/chem.202200264
Top S. Kaloun E.B. Vessières A. Leclercq G. Laïos I. Ourevitch M. Deuschel C. McGlinchey M.J. Jaouen G. Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour ChemBioChem 2003 4 754 761 10.1002/cbic.200200550 12898627
Top S. Vessières A. Cabestaing C. Laios I. Leclercq G. Provot C. Jaouen G. Studies on organometallic selective estrogen receptor modulators. (SERMs) Dual activity in the hydroxy-ferrocifen series J. Organomet. Chem. 2001 637–639 500 506 10.1016/S0022-328X(01)00953-6
Pigeon P. Top S. Vessières A. Huché M. Hillard E.A. Salomon A.E. Jaouen G. Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior J. Med. Chem. 2005 48 2814 2821 10.1021/jm049268h
Bray F. Ferlay J. Soerjomataram I. Siegel R.L. Torre L.A. Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J. Clin. 2018 68 394 424 Erratum in CA Cancer J. Clin. 2020, 70, 313 10.3322/caac.21609
Defossez G. Le Guyader-Peyrou S. Uhry Z. Grosclaude P. Remontet L. Colonna M. Estimations Nationales de L’incidence et de la Mortalité par Cancer en France Métropolitaine Entre 1990 et 2018, Vol. 1–Tumeurs Solides Santé Publique France Saint-Maurice, France 2019 372
Mohamed A.H. Görmen M. El Arbi M. Msaddek M. Veitia M.S.-I. Synthesis of some new diarylmethanes by McMurry coupling reaction: Characterization and antibacterial activity Proceedings of the MOL2NET’18, Conference on Molecular, Biomedical & Computational Sciences and Engineering Paris, France 15 January 2018–20 January 2019 10.3390/mol2net-04-06134
Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays J. Immunol. Methods 1983 65 55 63 10.1016/0022-1759(83)90303-4
Bretin L. Pinon A. Bouramtane S. Ouk C. Richard L. Perrin M.-L. Chaunavel A. Carrion C. Bregier F. Sol V. et al. Photodynamic Therapy Activity of New Porphyrin-Xylan-Coated Silica Nanoparticles in Human Colorectal Cancer Cancers 2019 11 1474 10.3390/cancers11101474
Saur I.M.L. Panstruga R. Schulze-Lefert P. NOD-like receptor-mediated plant immunity: From structure to cell death Nat. Rev. Immunol. 2021 21 305 318 10.1038/s41577-020-00473-z
Pettersen E.F. Goddard T.D. Huang C.C. Couch G.S. Greenblatt D.M. Meng E.C. Ferrin T.E. UCSF Chimera-a visualization system for exploratory research and analysis J. Comput. Chem. 2004 25 1605 1612 10.1002/jcc.20084 15264254
Allouche A. Software News and Updates Gabedit—A Graphical User Interface for Computational Chemistry Softwares J. Comput. Chem. 2012 32 174 182 10.1002/jcc.21600 20607691
Wolber G. Langer T. LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters J. Chem. Inf. Model. 2004 45 160 169 10.1021/ci049885e 15667141
Available online: https://chemaxon.com/ (accessed on 20 May 2020)
Quiroga R. Villarreal M.A. Vinardo: A Scoring Function Based on Autodock Vina Improves Scoring, Docking, and Virtual Screening PLoS ONE 2016 11 e0155183 10.1371/journal.pone.0155183 27171006
Schrödinger, Inc. Schrödinger Release 2019-4: Maestro Schrödinger, Inc. New York, NY, USA 2019
Harder E. Damm W. Maple J. Wu C. Reboul M. Xiang J.Y. Wang L. Lupyan D. Dahlgren M.K. Knight J.L. et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins J. Chem. Theory Comput. 2016 12 281 296 10.1021/acs.jctc.5b00864
Trécourt F. Breton G. Bonnet V. Mongin F. Marsais F. Quéguiner G. New Syntheses of Substituted Pyridines via Bromine–Magnesium Exchange Tetrahedron 2001 56 1349 1360 10.1016/S0040-4020(00)00027-2
Seto M. Aramaki Y. Imoto H. Aikawa K. Oda T. Kanzaki N. Iizawa Y. Baba M. Shiraishi M. Orally Active CCR5 Antagonists as Anti-HIV-1 Agents 2: Synthesis and Biological Activities of Anilide Derivatives Containing a Pyridine N-Oxide Moiety Chem. Pharm. Bull. 2004 52 818 829 10.1248/cpb.52.818
Goya-Jorge E. Rampal C. Loones N. Barigye S.J. Carpio L.E. Gozalbes R. Ferroud C. Veitía M.S.-I. Giner R.M. Targeting the aryl hydrocarbon receptor with a novel set of triarylmethanes Eur. J. Med. Chem. 2020 207 112777 10.1016/j.ejmech.2020.112777
Sui J.-J. Xiong D.-C. Ye X.-S. Copper-mediated O-arylation of lactols with aryl boronic acids Chin. Chem. Lett. 2019 30 1533 1537 10.1016/j.cclet.2019.06.014
Zekri O. Hillard E.A. Top S. Vessières A. Pigeon P. Plamont M.-A. Huché M. Boutamine S. Mcglinchey M.J. Müller-Bunz H. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds Dalt. Trans. 2009 4318 4326 10.1039/b819812h
Guo Y. Pan W. Liu S. Shen Z. Xu Y. Hu L. ERK/MAPK signalling pathway and tumorigenesis Exp. Ther. Med. 2020 19 1997 2007 10.3892/etm.2020.8454 32104259
Sun Y. Liu W.-Z. Liu T. Feng X. Yang N. Zhou H.-F. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis J. Recept. Signal Transduct. 2015 35 600 604 10.3109/10799893.2015.1030412 26096166
Ye Q. Cai W. Zheng Y. Evers B.M. She Q.-B. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer Oncogene 2014 33 1828 1839 10.1038/onc.2013.122
Loesch M. Chen G. The p38 MAPK stress pathway as a tumor suppressor or more? Front. Biosci. J. Virtual Libr. 2008 13 3581 10.2741/2951
Khajeh E. Rasmi Y. Kheradmand F. Malekinejad H. Aramwit P. Saboory E. Daeihassani B. Nasirzadeh M. Crocetin suppresses the growth and migration in HCT-116 human colorectal cancer cells by activating the p-38 MAPK signaling pathway Res. Pharm. Sci. 2020 15 592 10.4103/1735-5362.301344
Papaliagkas V. Anogianaki A. Anogianakis G. Ilonidis G. The proteins and the mechanisms of apoptosis: A mini-review of the fundamentals Hippokratia 2007 11 108 113
Sulzyc-Bielicka V. Domagala P. Hybiak J. Majewicz-Broda A. Safranow K. Domagala W. Colorectal cancers differ in respect of PARP-1 protein expression arxiv 2012 1207.5956
Augustine T. Maitra R. Zhang J. Nayak J. Goel S. Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparib Investig. New Drugs. 2019 37 948 960 10.1007/s10637-018-00717-9 30612311
Adasme M.F. Linnemann K.L. Bolz S.N. Kaiser F. Salentin S. Haupt V.J. Schroeder M. PLIP 2021: Expanding the scope of the protein-ligand interaction profiler to DNA and RNA Nucleic Acids Res. 2021 49 W530 W534 10.1093/nar/gkab294
